Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Enjoy your FREE PREVIEW which shows only 2024 data and 25 documents. Contact Patent Forecast for full access.        


Search All Patents in Z-ARCHIVE-Cannabis

Patent US10729665

Issued 2020-08-04

Pharmaceutical Composition Comprising The Phytocannabinoids Cannabidivarin (cbdv) And Cannabidiol (cbd)

This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD). The composition is particularly safe and efficacious for use in the treatment of neurological conditions, characterized by hyper-excitability of the central nervous system, convulsions or seizures such as occur in epilepsy. Preferably the CBDV and the CBD are present with at least one non-cannabinoid component of cannabis such as one or more terpenes or a terpene fraction. More particularly the composition further comprises one or more cannabichromene type compounds. Particularly cannabichromene propyl variant (CBCV) and/or cannabichromene (CBC). More particularly still the composition is absent or substantially absent of other cannabinoids, including in particular tetrahydrocannabinol (THC) and tetrahydrocannabivarin (THCV), which would normally be present in significant amounts in cannabis chemotypes bred to contain a significant amount of CBDV and/or CBD.

Much More than Average Length Specification

View the Patent Matrix® Diagram to Explore the Claim Relationships

USPTO Full Text Publication >

1 Independent Claim

  • 1. A method for treating epilepsy comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD), absent of the cannabinoids tetrahydrocannabivarin (THCV) and tetrahydrocannabinol (THC), wherein the CBDV and CBD are present in a ratio of from 5:1 to 1:1 (CBDV:CBD).